P R AG UE
2 0 1 5
Dear Colleague,
On behalf of the NATA board of directors, it is my pleasure to invite you to
the 16th NATA Symposium on Patient Blood Management, Haemostasis and
Thrombosis that will take place on April 16-17, 2015 in Prague, Czech Republic.
Whether you participated or not in the first NATA symposium in Prague—10 years
ago, already!—no doubt we will all enjoy (re)discovering this historical
and architectural jewel of Central Europe.
Every year NATA attracts a wide international and multidisciplinary audience,
allowing delegates to share their experiences and network with a variety of
specialists in their respective fields of interest.
In line with our new mission statement—Promoting optimal patient blood
management, haemostasis and thrombosis in everyday clinical practice through a
multidisciplinary approach—the scientific programme covers a wide range of topics
that is sure to interest anaesthesiologists, intensivists, surgeons, haematologists
and transfusion medicine specialists.
C ZECH
R E P U B LI C
on Patient Blood Management, Haemostasis and Thrombosis
16 th Annual NATA Symposium
nata
April 16-17
This year, notwithstanding our well-established areas of interest, special emphasis
will be placed on evidence-based transfusion practice, optimal management of
bleeding, and the role of iron therapy in patient blood management.
I B
lood Procurement and Transfusion Risks
The scientific programme includes four practical workshops where a limited
number of participants will be offered an excellent opportunity for clinical
discussions and exchange of experience. The topics, carefully selected by the
scientific committee for these interactive workshops, are: available technologies
for cell salvage, management of massive bleeding, perioperative and emergency
management of oral anticoagulants, and design and conduct of clinical trials in
transfusion medicine.
I Optimising the Practice of Transfusion
I M
anagement of the Bleeding Patient
I T reatment of Anaemia and Iron Deficiency
in Patient Blood Management
I B
urning Questions on Haemostasis
and Thrombosis
Finally, don’t miss out on our special, annual features: the best posters’
presentations and the late-breaking news session present upcoming and recently
completed research. No doubt they will stir up a lot of discussion!
I P
ro/Con Debate: Using a Fixed
RBC:FFP:PLT Ratio in Massively
Bleeding Patients
More than ever, the annual NATA symposium will provide a unique opportunity
for stimulating and constructive exchanges across different specialties involved
in patient blood management.
I Best Posters
I Breaking News
I Workshops
We look forward to meeting you in Prague for this outstanding event.
Yours sincerely,
Jean-François Hardy
NATA Chair
Network for the Advancement
of Patient Blood Management,
Haemostasis and Thrombosis
www.nataonline.com
THURSDAY, April 16, 2015
8:45-9:00
About NATA
Welcome Address
Jean-François Hardy, Montreal, QC, Canada
LOOD PROCUREMENT AND TRANSFUSION RISKS
B
Rainer Moog, Berlin, Germany • Zdenka Gašová, Prague, Czech Republic
9:00-9:20
Optimal Management of Blood Donors
Sant-Rayn Pasricha, Oxford, UK
9:20-9:40
Stem-Cell-Derived Blood Products: Present and Future
Luc Douay, Paris, France
The Network for the Advancement
(No parallel session)
Haemostasis and Thrombosis
Transfusion-Related Immunomodulation: Yes, but What Does It Do to Our
Patients?
Jeffrey L. Carson, New Brunswick, NJ, USA
10:00-10:30 Questions and Answers
(NATA) is unique in that it provides a
9:40-10:00
multidisciplinary forum for dialogue
between haematologists, blood
Break
10:30-11:00
bankers, anaesthesiologists, surgeons
O
PTIMISING THE PRACTICE OF TRANSFUSION
> WORKSHOP
> WORKSHOP
Red Blood Cell Transfusion in Cardiac Surgery
11:00-11:20 Gavin Murphy, Leicester, UK
MANAGEMENT OF MASSIVE
BLEEDING
MANAGEMENT OF PATIENTS
ON ORAL ANTICOAGULANTS
Real-Time Clinical Decision Support to Improve Blood Utilization
11:20-11:40 Lawrence Tim Goodnough, Stanford, CA, USA
Sibylle A. Kozek-Langenecker,
Vienna, Austria
Charles-Marc Samama,
Paris, France
Methods to Implement Patient Blood Management
11:40-12:00 Kai Zacharowski, Frankfurt am Main, Germany
Pär I. Johansson,
Copenhagen, Denmark
Marcel Levi, Amsterdam,
The Netherlands
Hans Gombotz, Linz, Austria • Karel Cvachovec, Prague, Czech Republic
12:00-12:30 Questions and Answers
and other healthcare professionals
interested in promoting best clinical
practice in the fields of patient
blood management, haemostasis
and thrombosis. Recently, NATA’s
mission statement—Promoting
Lunch Break • Industry-Sponsored Satellite Symposia and Workshops
12:30-14:30
of Patient Blood Management,
optimal patient blood management,
M
ANAGEMENT OF THE BLEEDING PATIENT
> WORKSHOP
> WORKSHOP
haemostasis and thrombosis in
Crystalloids vs. Starches vs. Albumin: the Never-Ending Question
14:30-14:50 Philippe Van der Linden, Brussels, Belgium
HOW TO SET UP A CLINICAL
TRIAL
everyday clinical practice through
Should We Be Using Fibrinogen Concentrate or Cryoprecipitate?
14:50-15:10 Jakob Stensballe, Copenhagen, Denmark
Beverley J. Hunt,
London, UK
CELL SALVAGE FOR THE
INEXPERIENCED—AN
OVERVIEW OF THE AVAILABLE
TECHNOLOGIES
Pär I. Johansson, Copenhagen, Denmark • Vladimir Černý, Ústí nad Labem, Czech Republic
Jeffrey L. Carson,
New Brunswick, NJ, USA
Antifibrinolytics to Reduce or Prevent Bleeding
15:10-15:30 Yves Ozier, Brest, France
15:30-16:00 Questions and Answers
16:00-16:30
Dafydd Thomas, Swansea,
Wales, UK
Jens Meier, Linz, Austria
a multidisciplinary approach—was
modified in order to better reflect the
various clinical issues encountered
in the management of anaemia,
Break
bleeding and thrombosis.
BEST POSTERS’ PRESENTATION
Charles-Marc Samama, Paris, France • Karel Cvachovec, Prague, Czech Republic
Autologous Transfusion of Stored Red Blood Cells Increases Pulmonary Artery
16:30-16:45 Pressure
Riccardo Pinciroli, Boston, MA, USA
Impact of Individual Physician Blood Reports and
16:45-17:00 “1 vs. 2 Unit” Metric to Lower Red Blood Cell Transfusions
Kathleen E. Puca, Milwaukee, WI, USA
Cerebrovascular Response to Infusion of EAF P5K6-Alb, NO Producing, Colloidal
Plasma Volume Expander, Is Muted in Transgenic Mouse Models of Sickle Cell
17:00-17:15 Disease
Craig A. Branch, Bronx, NY, USA
17:15-17:30 Tranexamic Acid Reduces Transfusion Requirements in Adult Major Spine Surgery
Jean-François Hardy, Montreal, QC, Canada
17:45-18:30 NATA General Assembly
www.nataonline.com
(No parallel session)
Network for the Advancement
of Patient Blood Management,
Haemostasis and Thrombosis
FRIDAY, April 17, 2015
ORGANIZING COMMITTEE
BREAKING NEWS
Chairs
J.-F. Hardy, Montreal, QC, Canada
Jean-François Hardy, Montreal, QC, Canada • Dafydd Thomas, Swansea, Wales, UK
8:40-9:00
Length of Red Blood Cell Storage and Clinical Outcomes in Transfused Critical Ill Adults—
The Age of Blood Evaluation (ABLE) Randomised Controlled Trial
Jacques Lacroix, Montreal, QC, Canada
9:00-9:20
Liberal Versus Restrictive Red Blood Cell Transfusion in ICU Patients with Septic Shock—
The Transfusion Requirements in Septic Shock (TRISS) Trial
Lars B. Holst, Copenhagen, Denmark
9:20-9:40
Long-Term Mortality in the Transfusion Trigger Trial for Functional Outcomes in
Cardiovascular Patients Undergoing Surgical Hip Fracture Repair (FOCUS)
Jeffrey L. Carson, New Brunswick, NJ, USA
9:40-10:00
Fibrinogen Concentrate as Initial Treatment for Postpartum Haemorrhage: FIB-PPH Study
Anne Wikkelsø, Copenhagen, Denmark
(No parallel session)
SCIENTIFIC COMMITTEE
Chair
C.-M. Samama, Paris, France
10:00-10:30 Questions and Answers
Break
10:30-11:00
TREATMENT OF ANAEMIA AND IRON DEFICIENCY IN PATIENT BLOOD MANAGEMENT
Manuel Muñoz, Málaga, Spain • Jaroslav Cermak, Prague, Czech Republic
Anaemia Does Not Fatigue You; Functional Iron Deficiency Does
11:00-11:20 Lawrence Tim Goodnough, Stanford, CA, USA
Management of Anaemia and Iron Deficiency in Pregnancy and in the Postpartum Period
11:20-11:40 Christian Breymann, Zurich, Switzerland
Management of Anaemia and Iron Deficiency in Elective Surgical Patients
11:40-12:00 Elvira Bisbe, Barcelona, Spain
> WORKSHOP
> WORKSHOP
HOW TO SET UP A CLINICAL
TRIAL
MANAGEMENT OF PATIENTS
ON ORAL ANTICOAGULANTS
Beverley J. Hunt,
London, UK
Charles-Marc Samama,
Paris, France
Jeffrey L. Carson,
New Brunswick, NJ, USA
David Faraoni,
Brussels, Belgium
12:00-12:30 Questions and Answers
12:30-14:30
Lunch Break • Industry-Sponsored Satellite Symposia and Workshops
BURNING QUESTIONS ON HAEMOSTASIS AND THROMBOSIS
Charles-Marc Samama, Paris, France • Peter Salaj, Prague, Czech Republic
Oral Anticoagulants: Update for 2015
14:30-14:50 Marcel Levi, Amsterdam, The Netherlands
Specific and Non-Specific Reversal of Target-Specific Oral Anticoagulants
14:50-15:10 David Faraoni, Brussels, Belgium
Viscoelastic Methods (TEG and ROTEM): Have We Progressed?
15:10-15:30 Beverley J. Hunt, London, UK
> WORKSHOP
> WORKSHOP
MANAGEMENT OF MASSIVE
BLEEDING
CELL SALVAGE FOR THE
INEXPERIENCED—AN
OVERVIEW OF THE AVAILABLE
TECHNOLOGIES
Sibylle A. Kozek-Langenecker,
Vienna, Austria
Pär I. Johansson,
Copenhagen, Denmark
Dafydd Thomas,
Swansea, Wales, UK
Jens Meier, Linz, Austria
15:30-16:00 Questions and Answers
PRO/CON DEBATE: USING A FIXED RBC:FFP:PLT RATIO IN MASSIVELY BLEEDING PATIENTS
^
Con: A 1:1:1 Ratio Is Useless
16:50-17:10 Sibylle A. Kozek-Langenecker, Vienna, Austria
17:10-17:30 Discussion
Concluding Comments
17:30-17:45 Jean-François Hardy, Montreal, QC, Canada • Charles-Marc Samama, Paris, France
--
Venue
Registration/Information
Jens Meier, Linz, Austria • Ivan Cundrle, Brno, Czech Republic
Pro: A 1:1:1 Ratio Should Be Used
Pär I. Johansson, Copenhagen, Denmark
Members
M. Auerbach, Baltimore, MD, USA
E. Bisbe, Barcelona, Spain
C. Breymann, Zurich, Switzerland
J. L. Carson, New Brunswick, NJ, USA
D. Faraoni, Brussels, Belgium
D. A. Fergusson, Ottawa, ON, Canada
T. Frietsch, Marburg, Germany
J. A. García-Erce, Zaragoza, Spain
A. Godier, Paris, France
H. Gombotz, Linz, Austria
L. T. Goodnough, Stanford, CA, USA
O. Habler, Frankfurt, Germany
E. Hansen, Regensburg, Germany
B. J. Hunt, London, UK
G. Inghilleri, Milan, Italy
M. Intaglietta, La Jolla, CA, USA
P. I. Johansson, Copenhagen, Denmark
S. A. Kozek-Langenecker, Vienna, Austria
J. Lacroix, Montreal, QC, Canada
S. R. Leal-Noval, Seville, Spain
M. Levi, Amsterdam, The Netherlands
J. Meier, Linz, Austria
R. Moog, Cottbus, Germany
H. Morimatsu, Okayama, Japan
M. Muñoz, Málaga, Spain
H. V. New, London, UK
Y. Ozier, Brest, France
M. Piagnerelli, Charleroi, Belgium
T. Richards, London, UK
J. Stensballe, Copenhagen, Denmark
D. Thomas, Swansea, Wales, UK
A. G. Tsai, La Jolla, CA, USA
C. E. Vagianos, Piraeus, Greece
P. Van der Linden, Brussels, Belgium
Prague Congress Centre
5. kvetna 65, 140 21 Prague 4
www.kcp.cz
16:00-16:30 Break
16:30-16:50
Members
E. Bisbe, Barcelona, Spain
H. Gombotz, Linz, Austria
P. I. Johansson, Copenhagen, Denmark
M. Levi, Amsterdam, The Netherlands
J. Meier, Linz, Austria
R. Moog, Cottbus, Germany
M. Muñoz, Málaga, Spain
C.-M. Samama, Paris, France
D. Thomas, Swansea, Wales, UK
(No parallel session)
NATA c/o MedEd Global Solutions
27 rue Raffet, 75016 Paris, France
Phone +33 142 536 009
Fax +33 141 103 667
E-mail: [email protected]
Website : www.nataonline.com